OXYSURE SYSTEMS INC Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2016-04-12: Form 8-K; Period of report 2016-04-12; Description 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Details 5.03.
- 2016-01-28: Form 8-K; Period of report 2016-01-28; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2015-12-02: Form 8-K; Period of report 2015-12-02; Description 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 7.01 Regulation FD Disclosure; Details 5.03.
- 2015-11-09: Form 8-K; Period of report 2015-11-09; Description 7.01 Regulation FD Disclosure; Details 7.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2016-04-12 | 8-K | 2016-04-12 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 5.03 On April 6, 2016, OxySure Therapeutics, Inc. (the “Company” or “OxySure”) filed an as corrected amendment to Article Four of the Company’s Articles of Incorporation with the Secretary of State in Delaware. | f8k041216_oxysuretherap.htm |
| 2016-01-28 | 8-K | 2016-01-28 | 7.01 Regulation FD Disclosure | 7.01 On January 27, 2016, OxySure Therapeutics, Inc. (the “Company”), the Board of Directors of the Company and certain stockholders of the Company filed a letter with the office of U.S. Senator John Cornyn requesting referrals to the Securities and Exchange Commission and other authorities to initiate investigations into certain manipulative short selling, naked short selling or other illegal short selling activities relating to the trading of the Company’s common stock. | f8k012716_oxysuretherap.htm |
| 2015-12-02 | 8-K | 2015-12-02 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 7.01 Regulation FD Disclosure | 5.03 Effective November 30, 2015, the Company changed its name from “OxySure Systems, Inc.” to “OxySure Therapeutics, Inc.” (the “Name Change”) by filing a certificate of amendment (“Certificate of Amendment”) to its Articles of Incorporation with the Secretary of State of the State of Delaware. 7.01 On December 2, 2015, the Company issued a press release announcing the Name Change. | f8k12215_oxys.htm |
| 2015-11-09 | 8-K | 2015-11-09 | 7.01 Regulation FD Disclosure | 7.01 On November 9, 2015, OxySure Systems, Inc. (the “Company”) issued a press release announcing that the Company’s Board of Directors approved a change of the Company’s name to OxySure Therapeutics, Inc. A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference. | f8k110915_oxysuresystems.htm |
| 2015-11-09 | 8-K | 2015-11-09 | 7.01 Regulation FD Disclosure | 7.01 On November 3, 2015, OxySure Systems, Inc. (the “Company”) issued a press release announcing that it filed a lawsuit in the Texas District Court in Collin County, Texas, against TEGNA Inc., WFAA T.V. Channel 8, Jobin Panicker, a reporter for WFAA T.V., The Redwine Law Firm PLLC (the “Redwine Law Firm”), and Symone Redwine, an attorney at the Redwine Law Firm (“Redwine,” and together with the Redwine Law Firm, the “Redwine Defendants”). | f8k110915_oxysuresystems.htm |
| 2015-09-17 | 8-K | 2015-09-15 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 At the Company’s Special Meeting of Stockholders held on September 15, 2015, the Company’s stockholders voted on, and approved, two proposals, the final voting results of which are provided below. | f8k091515_oxysuresys.htm |
| 2015-07-17 | 8-K | 2015-07-14 | 8.01 Other Events | 8.01 On June 30, 2015, OxySure Systems, Inc. (the “Company”) issued $2.7 million in its convertible preferred stock (“Series C, Series D and Series E Preferred Stock”) and $.3 million in 2 convertible notes (“Convertible Notes”). | f8k071415_oxysuresystems.htm |
| 2015-07-08 | 8-K/A | 2015-06-30 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 7.01 Regulation FD Disclosure | 1.01 Entry into a Material Definitive Agreement. 3.02 The information disclosed in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.02. 7.01 On July 7, 2015, the Company issued a press release announcing the financing. | f8k063015a1_oxysuresyste.htm |
| 2015-07-07 | 8-K | 2015-06-30 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 7.01 Regulation FD Disclosure | 1.01 Entry into a Material Definitive Agreement. 3.02 The information disclosed in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.02. 7.01 On July 7, 2015, the Company issued a press release announcing the financing. | f8k063015_oxysuresyste.htm |
| 2015-04-13 | 8-K | 2015-04-06 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On April 7, 2015, OxySure Systems, Inc. (the “Company”) entered into a letter agreement with Thomas J. Cox to serve on the Company’s Board of Directors. | f8k041015_oxysure.htm |
| 2015-03-31 | 8-K | 2015-03-31 | 7.01 Regulation FD Disclosure | 7.01 On March 31, 2015, the Company held an earnings conference call to discuss its financial and operating results for the three months and the year ended December 31, 2014. | f8k033115_oxysuresystem.htm |
| 2015-01-20 | 8-K | 2015-01-12 | 1.01 Entry into a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 1.01 Entry into a Material Definitive Agreement. 5.02 The information set forth in Item 5.02(c) above regarding the compensation arrangements are hereby incorporated by reference. | f8k011215_oxysure.htm |
| 2015-01-06 | 8-K | 2014-12-29 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 7.01 Regulation FD Disclosure | 1.01 Entry into a Material Definitive Agreement. 3.02 The information disclosed in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.02. 7.01 On January 6, 2015, the Company issued a press release announcing the financing. | f8k122914_oxysuresystems.htm |
| 2014-11-26 | 8-K | 2014-11-21 | 1.02 Termination of a Material Definitive Agreement | 1.02 On October 21, 2014, OxySure Systems, Inc. entered into a definitive agreement (“Agreement”) related to a merger with Estill Medical Technologies, Inc. The Agreement provided that either party could terminate the Agreement and abandon the transactions contemplated thereby by giving written notice to the other party if the closing did not occur on or before 5:00 p.m., Dallas, Texas time, on November 19, 2014. | f8k112114_oxysure.htm |
| 2014-10-24 | 8-K | 2014-10-21 | 1.01 Entry into a Material Definitive Agreement; 7.01 Regulation FD Disclosure | 1.01 Entry into a Material Definitive Agreement. 7.01 On October 23, 2014, the Company and Estill held a joint conference call to discuss the Merger. | f8k102114_oxysuresystem.htm |
| 2014-09-19 | 8-K | 2014-09-17 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On September 18, 2014, OxySure Systems, Inc. (“OxySure” or the “Company”) announced that the Company has appointed Clark E. Hood as Vice President, Resuscitation Sales Worldwide with an effective date of October 1, 2014. | f8k091714_oxysuresystems.htm |
| 2014-09-10 | 8-K | 2014-09-04 | 1.01 Entry into a Material Definitive Agreement | 1.01 – Entry into a Material Definitive Agreement. | f8k090414_oxysuresystems.htm |
| 2014-03-31 | 8-K | 2013-12-31 | 8.01 Other Events | 8.01 On March 31, 2014, OxySure Systems, Inc. (the “Company”) issued a press release in which the Company discloses that its annual filing on form 10-K will be delayed as further explained in the press release, a copy of which is furnished herewith as Exhibit 99.1. | f8k033114_oxysure.htm |
| 2014-03-21 | 8-K | 2014-03-21 | 7.01 Regulation FD Disclosure | 7.01 On March 21, 2014, OxySure Systems, Inc. (“OxySure” or the “Company”) issued a statement announcing the passing of one of its Directors, Mr. Don Reed, who died peacefully at his home in Argyle, Texas on March 5th, 2014. | f8k032114_oxysure.htm |
| 2014-03-10 | 8-K | 2014-03-10 | 8.01 Other Events | 8.01 During the week of March 10, 2014, Julian Ross, the Company’s President and Chief Executive Officer, will present the Company’s business plan to institutional buyside investors during a non-deal roadshow in New York. | f8k030714_oxysure.htm |
| 2014-03-03 | 8-K | 2014-03-03 | 2.02 Results of Operations and Financial Condition | 2.02 On March 3, 2014, OxySure Systems, Inc. (the “Company”) issued a press release in which the Company discloses its cash position as at December 31, 2013 to be in excess of $657,000. | f8k030314_oxysuresys.htm |
| 2014-01-29 | 8-K | 2014-01-23 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 7.01 Regulation FD Disclosure | 1.01 Entry into a Material Definitive Agreement. 3.02 The information disclosed in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.02. 7.01 On January 27, 2014, the Company issued a press release announcing the conversions and Lease Extension. | f8k012314_oxysuresystems.htm |
| 2014-01-02 | 8-K | 2013-12-26 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 7.01 Regulation FD Disclosure | 1.01 Entry into a Material Definitive Agreement. 3.02 The information disclosed in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.02. 7.01 On January 2, 2014, the Company issued a press release announcing the $750,000 financing. | f8k122613_oxysure.htm |
| 2013-12-20 | 8-K | 2013-12-19 | 8.01 Other Events | 8.01 On November 18, 2013, OxySure Systems, Inc. (“OxySure” or the “Company”) issued a press release announcing that the Company has entered into a distribution agreement with Pacific Medical Systems Ltd. A copy of the press release is furnished with this report as Exhibit 99.1. | f8k080213_oxysure.htm |
| 2013-08-06 | 8-K | 2013-08-02 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | f8k080213_oxysure.htm |
| 2013-08-05 | 8-K | 2013-08-01 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On August 1, 2013 the Company's Board of Directors dismissed Sam Kan & Company (“SKCO”) as the Company's independent registered public accounting firm effective immediately. | f8k080113_oxysure.htm |
| 2013-06-06 | 8-K | 2013-06-05 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On June 5, 2013, OxySure Systems, Inc. (the “Company”) entered into a fifth modification (the “Agreement Modification”) of that certain employment agreement between the Company and Julian T. Ross, dated January 15, 2009, as amended, for the fourth time on February 3, 2012 (the as-amended agreement, the “Agreement”). | f8k060613_oxysure.htm |
| 2013-03-26 | 8-K | 2013-03-26 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On March 26, 2013, OxySure Systems, Inc. (“OxySure” or the “Company”) announced that Mr. Jeremy M. Jones, former Chairman and CEO of Apria Healthcare is joining the Company as an independent director. | f8k032613_oxysure.htm |
| 2013-01-03 | 8-K | 2012-12-31 | 3.02 Unregistered Sales of Equity Securities; 7.01 Regulation FD Disclosure | 3.02 On January 3, 2013, OxySure Systems, Inc. (“OxySure” or the “Company”) announced the conversion of approximately $2.02 million in convertible notes to common stock. 7.01 A copy of the press release announcing the conversion described in Item 3.02 is furnished with this report as Exhibit 99.1. | f8k123112_oxysure.htm |
| 2012-11-15 | 8-K | 2012-11-15 | 7.01 Regulation FD Disclosure | 7.01 On November 14, 2012, OxySure Systems, Inc. (“OxySure” or the “Company”) issued a press release announcing the financial results for the Company’s fiscal quarter ended September 30, 2012 and that the Company was to host an investor conference call to discuss the quarterly results and update investors regarding corporate progress and developments. | f8k111512_oxysuresystemsinc.htm |
| 2012-08-31 | 8-K | 2012-08-29 | 3.02 Unregistered Sales of Equity Securities | 3.02 On August 29, 2012, OxySure Systems, Inc (“OxySure” or the “Company”) issued two warrants (“Warrants”) to Vencore Solutions LLC, a Delaware limited liability company (“Vencore”) pursuant to that certain second moratorium agreement entered into on July 9, 2012. | f8k082912_oxysure.htm |
| 2012-08-15 | 8-K | 2012-08-14 | 2.02 Results of Operations and Financial Condition | 2.02 On August 15, 2012, OxySure Systems, Inc (“OxySure” or the “Company”) issued a press release announcing the financial results for the Company’s fiscal quarter ended June 30, 2012. | f8k081512_oxysure.htm |
| 2012-07-31 | 8-K | 2012-07-26 | 7.01 Regulation FD Disclosure | 7.01 – Regulation FD Disclosure. | f8k072612_oxysure.htm |
| 2012-07-13 | 8-K | 2012-07-09 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | f8k070912_oxysure.htm |
| 2012-06-28 | 8-K | 2012-06-28 | 3.02 Unregistered Sales of Equity Securities | 3.02 On June 25, 2012, OxySure Systems, Inc. (the “Company”) received a conversion notice (the “Conversion Notice”) from the M. Nyewe Trust (“MN Trust”), converting the entire principal and accrued interest of a convertible note issued to MN Trust into common stock. | f8k062812_oxysure.htm |
| 2012-06-14 | 8-K | 2012-06-13 | 7.01 Regulation FD Disclosure | 7.01 – Regulation FD Disclosure. | f8k061312_oxysure.htm |
| 2012-05-04 | 8-K | 2012-05-03 | 1.01 Entry into a Material Definitive Agreement | 1.01 On May 3, 2012, the Company received fully executed agreements (“Agreements”) documenting the extension of the maturities of that certain First Landlord Note (“First Landlord Note”) and Second Landlord Note (“Second Landlord Note”) (collectively, the “Notes”), and the conversion of the Notes into common stock. | v311990_8k.htm |
| 2012-04-09 | 8-K | 2012-04-06 | 8.01 Other Events | 8.01 On April 6, 2012, OxySure Systems, Inc (“OxySure” or the “Company”) issued a press release announcing a conference call to discuss recent developments and financial results. | v308817_8k.htm |
| 2012-04-02 | 8-K | 2012-03-30 | 2.02 Results of Operations and Financial Condition | 2.02 On March 30, 2012, OxySure Systems, Inc (“OxySure” or the “Company”) issued a press release announcing financial results for the Company’s fiscal year ended December 31, 2011. | v308117_8k.htm |
| 2012-03-15 | 8-K | 2012-03-15 | 1.01 Entry into a Material Definitive Agreement | 1.01 On March 15, 2012, OxySure Systems, Inc. (the “Company”) issued a press release regarding its entry into a supplier agreement with W.W. Grainger, Inc. A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. | v306202_8k.htm |
| 2012-02-06 | 8-K | 2012-02-06 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On February 3, 2012, OxySure Systems, Inc. (the “Company”) entered into a fourth modification (the “Agreement Modification”) of that certain employment agreement between the Company and Julian T. Ross, dated January 15, 2009, as amended, for the second time on June 23, 2009, and as further amended for the third time on January 15, 2010 (the as-amended agreement, the “Agreement”). | v301316_8-k.htm |
| 2012-02-02 | 8-K | 2012-02-02 | 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | 2.03 On January 29, 2012, OxySure Systems, Inc. (the “Company”) entered into a Note Purchase Agreement (the “Agreement”) with the M. Nyewe Trust (the “Nyewe Trust”). | v301110_8k.htm |
| 2011-11-16 | 8-K | 2011-11-16 | 1.01 Entry into a Material Definitive Agreement | 1.01 On November 14, 2011, the Company reached agreement to modify each of the maturities of that certain Agave First Note and that certain JTR Second Note to April 15, 2013. | v240695_8k.htm |
| 2011-10-17 | 8-K | 2011-10-17 | 3.02 Unregistered Sales of Equity Securities | 3.02 On October 13, 2011, OxySure Systems, Inc. (the “Company”) received a conversion notice (the “Conversion Notice”) from Afritex Medical Products (Pty) Ltd. (“Afritex”), converting the entire principal and accrued interest of a convertible note issued to Afritex into common stock. | v237393_8k.htm |
| 2011-08-19 | 8-K | 2011-08-15 | 1.01 Entry into a Material Definitive Agreement | 1.01 On August 15, 2011, OxySure Systems, Inc. (the “Company”) entered into a Letter Agreement (the “Agreement”) with Sinacola Commercial Properties, Ltd. (“Sinacola”). | oxysure_8k-081511.htm |